"Point Of Novelty" Test Remains For Design Patent Infringement
Client Alert | 1 min read | 02.23.06
In Lawman Armor Corporation v. Winner International, LLC et al. (No. 05-1253; February 22, 2006), a Federal Circuit panel affirms a district court's summary judgment of non-infringement of a design patent for a vehicle steering wheel lock assembly. In the district court , Lawman identified eight points of novelty of the patented design , to which Winner responded by identifying patents depicting each of those eight points. Accordingly, the district court found that the points of novelty were found in the prior art and granted summary judgment of non-infringement. The panel finds that Lawman made no attempt to show that the district court erred in its decision providing that the eight points of novelty are disclosed in the prior art. The Federal Circuit panel rejects Lawman's argument that there was no suggestion to combine the prior art elements to achieve the patented design, essentially arguing that the combination of the prior art elements is itself a ninth point of novelty. This decision maintains the long-standing "point of novelty" design patent infringement test, namely, that an accused device must appropriate the novel features of the patented design, specifically those features that distinguish it from the prior art.
Insights
Client Alert | 11 min read | 12.15.25
New York LLC Transparency Act: Key Requirements and Deadlines
On January 1, 2026 (“Effective Date”), the New York LLC Transparency Act ("New York Act”) is scheduled to take effect, introducing new disclosure requirements for limited liability companies (“LLCs”) formed or registered to do business in New York State. The New York Act is expected to impose the type of broad beneficial ownership requirements the federal CTA and rules implementing it was designed to require, before the federal government’s decision to limit the scope of the CTA’s beneficial ownership reporting requirements to foreign companies and foreign beneficial owners.
Client Alert | 7 min read | 12.15.25
The New EU “Pharma Package:” EU Reaches Landmark Deal on Pharma Package
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
